Literature DB >> 21213409

Clarification of the phenotypic characteristics and anti-tumor activity of Hedyotis diffusa.

Hong-Zin Lee1, Da-Tian Bau, Chao-Lin Kuo, Ru-Yin Tsai, Yu-Chang Chen, Yu-Hao Chang.   

Abstract

Hedyotis diffusa Willd. (Rubiaceae) is an important folk herb used to prevent and cure hepatitis and liver cancer in Taiwan. For differentiation of H. diffusa from counterfeits, macroscopic and microscopic characters of H. diffusa, H. corymbosa and H. tenelliflora were examined in this study. According to Trypan blue exclusion assay and Western blot analysis, H. diffusa had a significant inhibition of cell growth and induction of cell apoptosis in COLO 205 (colon cancer), Hep 3B (hepatocellular carcinoma) and H460 (lung cancer) cell lines. This study also used high-performance liquid chromatography (HPLC) to determine the quality control of H. diffusa. The HPLC data showed that ursolic and oleanolic acid are the components of the H. diffusa, consisting of approximately 4.66-4.80% and 1.86-1.96%, respectively. Our study also demonstrated that ursolic acid has significant anti-tumor activity in COLO 205, Hep 3B and H460 cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21213409     DOI: 10.1142/S0192415X11008750

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  16 in total

1.  Total flavonoids of Hedyotis diffusa Willd inhibit inflammatory responses in LPS-activated macrophages via suppression of the NF-κB and MAPK signaling pathways.

Authors:  Yunlong Chen; Yanyan Lin; Yachan Li; Candong Li
Journal:  Exp Ther Med       Date:  2015-12-29       Impact factor: 2.447

2.  Combination of HDE and BIIB021 efficiently inhibits cell proliferation and induces apoptosis via downregulating hTERT in myelodysplastic syndromes.

Authors:  Bo Wang; Jianping Jiang; Yun Zhang; Yingying Shen; Liqiang Wu; Siqi Tang; Shengyun Lin
Journal:  Exp Ther Med       Date:  2021-03-17       Impact factor: 2.447

3.  Chloroform extract of Hedyotis diffusa Willd inhibits viability of human colorectal cancer cells via suppression of AKT and ERK signaling pathways.

Authors:  Zhaokun Yan; Jianyu Feng; Jun Peng; Zijun Lai; Ling Zhang; Yiyi Jin; Hong Yang; Wujin Chen; Jiumao Lin
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

4.  Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite.

Authors:  Grace Gar-Lee Yue; Julia Kin-Ming Lee; Hin-Fai Kwok; Ling Cheng; Eric Chun-Wai Wong; Lei Jiang; Hua Yu; Hoi-Wing Leung; Yuk-Lau Wong; Ping-Chung Leung; Kwok-Pui Fung; Clara Bik-San Lau
Journal:  Sci Rep       Date:  2015-06-08       Impact factor: 4.379

5.  Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study.

Authors:  Tzung-Yi Tsai; Hanoch Livneh; Tsung-Hsing Hung; I-Hsin Lin; Ming-Chi Lu; Chia-Chou Yeh
Journal:  BMJ Open       Date:  2017-01-25       Impact factor: 2.692

6.  A Methodology for Cancer Therapeutics by Systems Pharmacology-Based Analysis: A Case Study on Breast Cancer-Related Traditional Chinese Medicines.

Authors:  Yan Li; Jinghui Wang; Feng Lin; Yinfeng Yang; Su-Shing Chen
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

Review 7.  Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine.

Authors:  Yulin Zhang; Yeer Liang; Chengwei He
Journal:  Chin Med       Date:  2017-07-12       Impact factor: 5.455

8.  Ezrin dephosphorylation/downregulation contributes to ursolic acid-mediated cell death in human leukemia cells.

Authors:  G Li; T Zhou; L Liu; J Chen; Z Zhao; Y Peng; P Li; N Gao
Journal:  Blood Cancer J       Date:  2013-04-12       Impact factor: 11.037

9.  A Network Pharmacology Approach to Uncover the Multiple Mechanisms of Hedyotis diffusa Willd. on Colorectal Cancer.

Authors:  Xinkui Liu; Jiarui Wu; Dan Zhang; Kaihuan Wang; Xiaojiao Duan; Xiaomeng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-12       Impact factor: 2.629

10.  Exploring the Interaction Mechanism Between Cyclopeptide DC3 and Androgen Receptor Using Molecular Dynamics Simulations and Free Energy Calculations.

Authors:  Huimin Zhang; Tianqing Song; Yizhao Yang; Chenggong Fu; Jiazhong Li
Journal:  Front Chem       Date:  2018-04-19       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.